Belize vs Norway: Reported paralytic polio cases per million
Belize
0 cases per million
in 2000
Norway
0 cases per million
in 2023
Belize rank
26th
Norway rank
26th
Reported paralytic polio cases per million over time
- Belize
- Norway
How they compare
Belize currently reports 0 cases per million against 0 cases per million in Norway, a difference of 0 cases per million.
The two have swapped places 1 time across 21 shared years of data; in 1980 it was Belize ahead.
Belize ranks 26th and Norway ranks 26th of 199 countries.
Across the 3 decades both report, Belize averaged higher in 1 and Norway in 1.
Head to head by decade
| Decade | Belize | Norway | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.07 cases per million | 0.0487 cases per million | 2.02 cases per million | Belize |
| 1990s | 0 cases per million | 0.0233 cases per million | 0.0233 cases per million | Norway |
| 2000s | 0 cases per million | 0 cases per million | 0 cases per million | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported paralytic polio cases per million, Belize or Norway?
- Belize, at 0 cases per million against 0 cases per million in Norway as of 2000.
- What is the difference in reported paralytic polio cases per million between Belize and Norway?
- 0 cases per million, with Belize ahead.
- How many years of comparable data are there for Belize and Norway?
- 21 years are reported by both, from 1980 to 2000.
- How do Belize and Norway rank globally for reported paralytic polio cases per million?
- Belize ranks 26th and Norway ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024); Population based on various sources (2023) – with major processing by Our World in Data, published as Reported paralytic polio cases per million. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases per million people.